In Honor of Hans-Jörg Senn

por Thürlimann, Beat, Costa, Alberto, Cardoso, Fatima
Publicado 2023

Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects

por Herrmann, Christian, Morant, Rudolf, Walser, Esther, Mousavi, Mohsen, Thürlimann, Beat
Publicado 2021

40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland

por Herrmann, Christian, Ess, Silvia, Thürlimann, Beat, Probst-Hensch, Nicole, Vounatsou, Penelope
Publicado 2015

Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference()

por Gnant, Michael, Curigliano, Giuseppe, Senn, Hansjörg, Thürlimann, Beat, Weber, Walter P.
Publicado 2022

Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies

por Herrmann, Christian, Vounatsou, Penelope, Thürlimann, Beat, Probst-Hensch, Nicole, Rothermundt, Christian, Ess, Silvia
Publicado 2018

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal w...

por Regan, Meredith M, Price, Karen N, Giobbie-Hurder, Anita, Thürlimann, Beat, Gelber, Richard D
Publicado 2011

Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early br...

por Maranta, Angela Fischer, Broder, Simon, Fritzsche, Constanze, Knauer, Michael, Thürlimann, Beat, Jochum, Wolfram, Ruhstaller, Thomas
Publicado 2020

Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors

por Templeton, Arnoud J, Thürlimann, Beat, Baumann, Michael, Mark, Michael, Stoll, Sarah, Schwizer, Madeleine, Dietrich, Daniel, Ruhstaller, Thomas
Publicado 2013

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy:...

por Dowsett, Mitch, Sestak, Ivana, Regan, Meredith M., Dodson, Andrew, Viale, Giuseppe, Thürlimann, Beat, Colleoni, Marco, Cuzick, Jack
Publicado 2018

Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK)

por Hayoz, Stefanie, Kasenda, Benjamin, Schenker, Annina Lea, Kopp, Christoph, Schär, Sämi, Thürlimann, Beat, von Moos, Roger, Pless, Miklos
Publicado 2023

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99

por Eppenberger-Castori, Serenella, Klingbiel, Dirk, Ruhstaller, Thomas, Dietrich, Daniel, Rufle, Daniel Alexander, Rothgiesser, Karin, Pagani, Olivia, Thürlimann, Beat
Publicado 2020

Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study

por Varga, Zsuzsanna, Cassoly, Estelle, Li, Qiyu, Oehlschlegel, Christian, Tapia, Coya, Lehr, Hans Anton, Klingbiel, Dirk, Thürlimann, Beat, Ruhstaller, Thomas
Publicado 2015

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer

por Crombag, Marie-Rose B.S., Joerger, Markus, Thürlimann, Beat, Schellens, Jan H.M., Beijnen, Jos H., Huitema, Alwin D.R.
Publicado 2016

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmen...

por Buechler, Steven A, Gray, Kathryn P, Gökmen-Polar, Yesim, Willis, Scooter, Thürlimann, Beat, Kammler, Rosita, Viale, Giuseppe, Leyland-Jones, Brian, Badve, Sunil S, Regan, Meredith M
Publicado 2019

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

por Aapro, Matti, Cardoso, Fatima, Curigliano, Giuseppe, Eniu, Alexandru, Gligorov, Joseph, Harbeck, Nadia, Mueller, Andreas, Pagani, Olivia, Paluch-Shimon, Shani, Senkus, Elzbieta, Thürlimann, Beat, Zaman, Khalil
Publicado 2022

Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue

por Antonov, Janine, Popovici, Vlad, Delorenzi, Mauro, Wirapati, Pratyaksha, Baltzer, Anna, Oberli, Andrea, Thürlimann, Beat, Giobbie-Hurder, Anita, Viale, Giuseppe, Altermatt, Hans Jörg, Aebi, Stefan, Jaggi, Rolf
Publicado 2010

SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients

por Vetter, Marcus, Rothgiesser, Karin M, Li, Qiyu, Hawle, Hanne, Schönfeld, Wolfgang, Ribi, Karin, Riniker, Salome, von Moos, Roger, Trojan, Andreas, Kralidis, Elena, Fehr, Mathias, Müller, Andreas, Thürlimann, Beat
Publicado 2022

Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients

por Zweifel, Martin, Thürlimann, Beat, Riniker, Salome, Weder, Patrik, von Moos, Roger, Pagani, Olivia, Bigler, Martin, Rothgiesser, Karin M, Pilop, Christiane, Hawle, Hanne, Brauchli, Peter, Tapia, Coya, Schoenfeld, Wolfgang, Sessa, Cristiana
Publicado 2017

Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group T...

por Kensler, Kevin H., Regan, Meredith M., Heng, Yujing J., Baker, Gabrielle M., Pyle, Michael E., Schnitt, Stuart J., Hazra, Aditi, Kammler, Roswitha, Thürlimann, Beat, Colleoni, Marco, Viale, Giuseppe, Brown, Myles, Tamimi, Rulla M.
Publicado 2019

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data

por Schmid, Sabine, Klingbiel, Dirk, Aebi, Stefan, Goldhirsch, Aron, Mamot, Christoph, Munzone, Elisabetta, Nolè, Franco, Oehlschlegel, Christian, Pagani, Olivia, Pestalozzi, Bernhard, Rochlitz, Christoph, Thürlimann, Beat, von Moos, Roger, Weder, Patrik, Zaman, Khalil, Ruhstaller, Thomas
Publicado 2019